THE GLOBAL BREAST CANCER COMMUNITY
See the realities faced by patients with metastatic breast cancer (mBC) around the world and view some local initiatives to drive awareness and fight this disease.
APAC Region
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
THROUGH MY EYES
The awareness of metastatic breast cancer (mBC) is significantly low across the Asia Pacific (APAC) region. Through My Eyes is an initiative to address the low awareness and understanding of mBC in the APAC community. At the heart of the initiative are the stories of women living with mBC and their support network in APAC, as well as healthcare professionals who have dedicated their professional life to improving care of mBC patients. This forum provides a platform to share their journey and offer hope and support for other women living with mBC.
Learn More About Through My Eyes
Learn More
Argentina
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
PALABRA DE MUJER
Pfizer joined efforts with 4 NGOs to bring Palabra de Mujer (Woman’s Voice) to life. Palabra de Mujer is a dictionary built with the valuable contribution of 11 patients with metastatic breast cancer. These women’s experiences inevitably led them to look at life differently, and they have channeled their transformative wisdom into inspirational lessons that invite us all to reflect and appreciate life differently.
Find out more about Palabra de Mujer
Learn More
Initiatives
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
SPARC MBC CHALLENGE
The Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC MBC Challenge) is an initiative of the Union for International Cancer Control (UICC) supported by Pfizer that aims to empower advocacy groups, hospital networks, support groups, and other organizations worldwide as they initiate projects to address the specific needs of women living with metastatic breast cancer.
Grants are awarded for projects focused on closing the gap in information, support, awareness, and policy between metastatic breast cancer and early breast cancer, as well as helping reduce the number of women first diagnosed at the metastatic stage of the disease.
Find out more about the SPARC mBC Challenge and the UICC
Learn More
United Kingdom
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
BREAST CANCER NOW’S CATALYST PROGRAMME
Pfizer has committed £10 million (USD $15M) over 3 years to fund research proposed by the Breast Cancer Now Catalyst Programme. The Programme allows the scientific community to propose research projects based on their insights into patient needs and understanding of cancer therapies, bringing together industry, researchers, and funders to advance the development of breast cancer treatments.
Find out about Breast Cancer Now’s Catalyst Programme
Learn More
France
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
SEINCHRONE
SEINCHRONE is an initiative to champion for everyone affected by metastatic breast cancer (mBC). Through collaboration, we believe we can improve the lives of those living with metastatic breast cancer, optimize coordinated care, and provide a forum of support and encouragement for all.
Find out more about the SEINCHRONE initiative
Learn More
Australia
Who We’re Fighting For:
Belinda
Meet Belinda, a 40-year-old woman with mBC living in Sydney, Australia. Hear her talk about her diagnosis and how she cofounded a mBC support group.
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Turkey
Who We’re Fighting For:
YELIZ
Yeliz is a 40-year-old woman living with mBC in Istanbul, Turkey. Hear her talk about bringing awareness to the global mBC landscape from diagnosis to treatment for all those impacted.
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Spain
Who We’re Fighting For:
Amelia
Meet Amelia, a 51-year-old woman with mBC living in Aragón, Spain. Hear her talk about her diagnosis and how her friends and family helped support her throughout the process.
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
European Region
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
ME & METASTATIC BREAST CANCER
Some adults are fighting metastatic breast cancer (mBC). Others have loved ones with a new diagnosis. No matter their relationship with the disease, Me & mBC aims to help all those affected by offering solutions that are right for them. Our hope is that this site encourages all visitors to make the most of every day.
Find out more about Me & mBC
Learn More
BREAST CANCER MATTERS
Breast Cancer Matters brings together the voices and stories of those working every day to improve the lives of women living with breast cancer (BC) and metastatic breast cancer (mBC). Physicians, patients, advocates, researchers, organizations, institutions, and decision makers provide their personal perspectives on BC and mBC and where improvements are needed.
Find out more about Breast Cancer Matters
Learn More
EMOTIONSPACE
Pfizer developed the EmotionSpace app, which enables women with metastatic breast cancer (mBC) to express emotions without judgment and ask for support if and when needed. The app was co‐created together with a group comprised of breast cancer patients and patient advocates to support women living with mBC in their daily lives.
The EmotionSpace app is available in select countries, as well as in the EU and beyond. EmotionSpace allows users to:
- Record and document their emotions
- Communicate their feelings to friends or family and ask for support when needed
- Generate a ʺfeelings curveʺ over time to share with their HCPs
- Search for nearby advocacy meetings and patient services
Find out more about EmotionSpace and download the app
Learn More
THE WHITE PAPER ON CANCER CARERS
This collaboration between the European Cancer Coalition and Eurocarers challenges specific policy and calls for legislative change. It's an action plan for elevating the quality of life of the unsung carers.
Access the White Paper on Cancer Carers
Learn More
THE 2017 mBC SUMMIT
Across borders and professions, the mBC Summit convenes to address the shortcomings in policy and care and to celebrate the achievements in the fight against metastatic breast cancer. By sharing knowledge and experience we improve the lives of women with mBC, because every day is precious.
View the 2017 mBC Summit Report
Download Now
mBC: COMMUNICATION AND CARE
The Consensus Recommendations on Communication between Healthcare Professionals and Patients: Prepare – Ask – Listen – Motivate (PALiMo) was a key output from the 2nd mBC Summit. The recommendations are a concord between 52 participants, including patients and key treatment team members from across the globe. The objective was to provide concrete and practical recommendations for possible inclusion in existing medical and scientific guidelines.
View the PALiMo Recommendations
Download Now
United States
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
A STORY HALF TOLD
A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.
Find out about A Story Half Told
Learn More
ADVANCING SCIENCE THROUGH PFIZER-INVESTIGATOR RESEARCH EXCHANGE (ASPIRE)
The ASPIRE program underscores Pfizer’s commitment to supporting investigators in advancing their academic research in advanced breast cancer and other therapeutic areas.
Find out about the ASPIRE program
Learn More
AVON-PFIZER METASTATIC BREAST CANCER GRANTS PROGRAM
Since 2014, Pfizer and the Avon Breast Cancer Crusade have partnered to establish the Avon-Pfizer Metastatic Breast Cancer Grants Program to address the gaps in support available to women and men living with mBC.
Find out more about Avon-Pfizer Metastatic Breast Cancer Grants Program
Learn More
BREAST CANCER RESEARCH FOUNDATION’S (BCRF) DRUG RESEARCH COLLABORATIVE
BCRF has received a 3-year, $15 million grant from Pfizer, along with access to all of Pfizer’s marketed and pipeline assets, to support its Drug Research Collaborative. The collaborative offers a new model for bridging the gap between academic investigators and the industry partners who can provide access to developmental oncology drugs.
The program will initially support 6 laboratory studies and 3 clinical trials that will collectively benefit nearly 400 patients with metastatic disease. The clinical studies will be conducted and managed by the Translational Breast Cancer Research Consortium (TBCRC).
Find out about BCRF’s Drug
Research Collaborative
Learn More
Mexico
Who We’re Fighting For:
Esther
Meet Esther, a 33-year-old woman with mBC living in Mexico City, Mexico. Hear her talk about her diagnosis and the strength she found in a support system.
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Brazil
Who We’re Fighting For:
Elfriede
Meet Elfriede, a 61-year-old woman from Saõ Paolo, Brazil. Hear her mBC story from diagnosis to treatment, and her support along the way.
Programs Supporting
Innovation in Breast Cancer
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
OUTUBRO ROSA: BREAST CANCER AWARENESS MONTH
Pink October is a worldwide campaign underscoring the importance of breast cancer awareness, education, and research. In an effort to support patients and address unmet needs, Pfizer and Oncoguia–a nonprofit association that helps cancer patient to live better—have joined together to celebrate those in the fight against metastatic breast cancer.